• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Laparoscopic Cholecystectomy in the Super Morbidly Obese Patients

Laparoscopic Cholecystectomy in the Super Morbidly Obese Patients

Muhammad Asad Khan, MD, Roman Grinberg, MD, Stelin Johnson, RPAC, John N Afthinos, MD, Karen E Gibbs, MD. Staten Island University Hospital

 

OBJECTIVE:

Laparoscopic cholecystectomy has been the accepted standard of care for the treatment of acute cholecystitis for over a decade. There is ongoing debate whether it is safe in the super morbidly obese patient with BMI ≥ 50 kg/m2. The current study compared the outcomes of super-obese (BMI ≥ 50 kg/m2) patients undergoing open vs. laparoscopic cholecystectomy.

METHODS:

We obtained data from the American College of Surgeons’ National Surgical Quality Improvement Program (NSQIP) on 1062 super-obese patients with a BMI ≥ 50 kg/m2 who underwent open and laparoscopic cholecystectomy between 2007 and 2009. The parameters analyzed included age, gender, co-morbid conditions, American Society of Anesthesiologists classification score, operative time, postoperative complications, re-operation, length of hospital stay and mortality.

RESULTS:

Among 1062 patients, 912 (85.9%) underwent laparoscopic cholecystectomy while 150 (14.1%) had open cholecystectomy. Mean age of the study population was 43.1 years and 80% were female. Among two groups, patients underwent laparoscopic procedures had significantly lower incidence of diabetes (20% vs. 36%), COPD (2.2% vs. 5.3%), HTN (44% vs. 66%) and bleeding disorder (2.9% vs. 20%). Operative time and length of hospital stay was significantly shorter in laparoscopic group as compared to open group (81 ± 40 min vs. 145±68 min and 1.7 ± 3.2 days vs. 9.2 ± 15.5 days, respectively). Nine patients (6%) in open cholecystectomy group underwent return to OR compare to only 1% patients in laparoscopic group. Similarly superficial, deep, organ space infection and wound dehiscence was significantly higher in open group, Patients in open cholecystectomy group had higher incidence of pneumonia, re-intubation, failure to wean, UTI, MI, cardiac arrest, sepsis and septic shock. Perioperative mortality was 3.3% in open cholecystectomy patients as compared to 0.2% in laparoscopic patients (p<0.01).

CONCLUSION:

Laparoscopic cholecystectomy is a safer option for super-obese patients and should be attempted in order to potentially avoid significant peri-operative complications in this high risk group.
 

Complications

Open cholecystectomy

N=150

Laparoscopic cholecystectomy P
Perioperative Complications
Reintubation 8 (5.3%) 4 (0.4%) .001
Failure to wean 11 (7.3%) 3 (0.3%) <.001
Progressive renal failure 7 (4.7%) 2 (0.2%) <.001
Urinary tract infection 4 (2.7%) 5 (0.5%) .027
Cardiac arrest 3 (2%) 0 (0%) .003
Myocardial infarction 2 (1.3%) 1 (0.1%) .054
Sepsis 6 (4%) 1 (0.1%) <.001
Septic Shock 10 (6.7%) 2 (0.2%) <.001
Pneumonia 8 (5.3%) 4 (0.4%) <.001

 


Session Number: Poster – Poster Presentations
Program Number: P481
View Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search